Navigation Links
BioConvergence® Presents Case Study on Temperature Controlled Pharmaceutical Products
Date:10/19/2013

shed processes for continual improvement moving forward

When asked how BioConvergence achieved these results, Hudson, Associate Process Engineer at BioConvergence, responded, “We began by having a clear picture of the results we wanted to see: improvements to key performance indicators and partnerships, as well as reductions to excursion rates. Next, we began an in-depth analysis of our existing processes and flagged five specific root causes that were interfering with outcomes. After strategically addressing each of these items, we began to see improvements in our metrics. This process has become the standard at BioC in promoting continual improvements.”

In addition to presenting this case study, Valentine and Hudson also led a roundtable discussion during the conference entitled, “How to Create Value through Designing and Implementing a Shipping Lane Qualification for High Value Pharmaceutical Products.”

To learn more about the framework BioConvergence developed, download the full case study at http://www.bioc.us/iqpc.

About BioConvergence

BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, BioC has over 50 employees with more than four centuries’ worth of combined experience in the pharmaceutical industry. BioC’s unique E-Transparency® System provides transparency and flexibility to its clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11245946.htm.


'/>"/>
Source: PRWeb
Copyright2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. BioConvergence®, Contract Manufacturing Organization for the Life Sciences Industry, Announces New Board of Directors
2. CEO of BioConvergence® Receives Women Excel Bloomington Award for Outstanding Leadership and Service
3. BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment
4. BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
5. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
6. Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
7. FarHawk Marketing Services Represents IonBench™ and MS Noise™ at the Greater Boston Mass Spectrometry Discussion Group Corporate Night October 3rd
8. San Francisco Business Times Presents: Richmond! Your Home Front for Business
9. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
10. Bayer CropScience Presents on Bee Health and Stewardship at International Pollinator Conference
11. Clinovo Presents Its Paper ‘Cloud for Clinical Trials’ at Society for Clinical Data Management (SCDM) Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... GraphDB™ 6.0 from ... to the enterprise replication cluster, faster loading speeds, ... and Elasticsearch. This release happens to coincide with ... – GraphDB™ was formerly known as OWLIM. ... mature enterprise resilient RDF triplestore will also benefit ...
(Date:8/19/2014)... 19, 2014 A Geisinger researcher on a ... a Centers for Disease Control and Prevention (CDC) award ... health concern. Joseph Boscarino , Ph.D. ... a team of researchers nominated for the Centers for ... Award for Data Methods and Study Design. ...
(Date:8/19/2014)... XenoTech announces an exclusive partnership ... production from bioactive small molecules. Based on ... enables convenient and timely assessment of critical metabolite ... President of Commercial Operations, Christian Darabant, “the value ... can be measured directly by comparison with the ...
(Date:8/19/2014)... 19, 2014   Synthetic Biologics, Inc. ... anti-infective biologic and drug programs targeting specific pathogens ... that its novel C. difficile development ... Interscience Conference on Antimicrobial Agents and Chemotherapy ... Synthetic Biologics, Senior Vice ...
Breaking Biology Technology:Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4
... Corporation (OTCBB:RONE), an emerging business development corporation that is ... companies, today announced it will distribute a special dividend ... stock. Regal One is assisting in the filing of ... and Exchange Commission, wherein these shares may be registered ...
... Alliance released the results of its Oncology National Commercial (ONC) ... report of the study,s findings is available at www.campbellalliance.com ... of the results with its clients by request. ... changes in the oncology market over the past 10 years ...
... 31, 2011 Enox Biopharma, Inc., a leader in ... medical devices, today announced that it has expanded its ... a patent application on novel means of delivering nitric ... well recognized as both an antimicrobial agent which can ...
Cached Biology Technology:Regal One Announces Dividend of Rampart Detection Systems Common Stock 2Oncology National Commercial (ONC) Study Outlines 10 Trends Shaping the Market for Oncology Pharmaceutical and Biotech Products 2Enox Biopharma, Inc. Expands Its Technology to Cover the Wound Care Market 2
(Date:8/19/2014)... systems be used in supermarkets to encourage healthier spending ... to answer that very question by tracking the purchasing ... Stars System to rate the nutritional value of foods ... Brand Lab,s David Just, PhD, and Brian Wansink PhD, ... records of over 150 Hannaford Supermarkets in the Northeastern ...
(Date:8/19/2014)... fish purchased at retail seafood counters in 10 ... can expose consumers to unexpectedly high levels of ... falsely present a fish of the same species, ... dangerous mislabeling offense, according to new research by ... labeling of seafood is essential to allow consumers ...
(Date:8/19/2014)... crocodiles colonised the seas during warm phases and became ... study which establishes a link between marine crocodilian diversity ... of more than 140 million years. , The ... de Lyon, France and formerly from the University of ... Communications ., Today, crocodiles are ,cold-blooded, animals that mainly ...
Breaking Biology News(10 mins):Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Evolution of marine crocodilians constrained by ocean temperatures 2
... of Colorado-Denver and Health Sciences Center and Stanford University ... respond to DNA damage and other acute stresses, and ... lead to new diagnostic markers and cancer treatments with ... the May 21 advanced online version of the journal ...
... forms could be the answer to one of today's ... future. Using a variety of natural food sources, ... fuels like ethanol and even boost the output of ... week at the 106th General Meeting of the (ASM) ...
... Tregs are a specialized subpopulation of T cells that ... harnessing the therapeutic potential of Tregs -- for example, ... arthritis -- is hampered by problems generating sufficient cells ... T cells, Tregs do not proliferate in vitro when ...
Cached Biology News:Researchers uncover new mechanism of tumor suppressor 2Research highlights how bacteria produce energy 2